Product Images Propafenone Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Propafenone Hydrochloride NDC 60687-674 by American Health Packaging, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

225 mg Propafenone Hydrochloride Extended Release Capsule Blister - 225 mg Blister

225 mg Propafenone Hydrochloride Extended Release Capsule Blister - 225 mg Blister

225 mg Propafenone Hydrochloride Extended Release Capsules Carton - 225 mg Carton

225 mg Propafenone Hydrochloride Extended Release Capsules Carton - 225 mg Carton

This is a description of a medicine called Propafenone Hydrochloride. The medicine is present in the form of extended-release capsules, USP. Each capsule contains 225mg of propafenone hydrochloride, and the usual dosage recommended is one capsule every 12 hours. The medicine should be kept at a temperature between 20-25 degrees Celsius and should be kept out of reach of children. The packaging is distributed by American Health Packaging, Columbus, Ohio.*

325 mg Propafenone Hydrochloride Extended Release Capsule Blister - 325 mg Blister

325 mg Propafenone Hydrochloride Extended Release Capsule Blister - 325 mg Blister

325 mg Propafenone Hydrochloride Extended Release Capsules Carton - 325 mg Carton

325 mg Propafenone Hydrochloride Extended Release Capsules Carton - 325 mg Carton

This is the label information of a medication containing Propafenone Hydrochloride in extended-release capsules format. The medication is prescribed and usually taken once every 12 hours. It is important to store the drug at room temperature and keep it out of reach of children. The package contains 20 capsules in total and the distributor is American Health Packaging based in Columbus, Ohio.*

AHP67432

AHP67432

AHP68532

AHP68532

Figure 1: RAFT Kaplan-Meier Analysis for the Tachycardia-free period from Day 1 of Randomization - Figure 1

Figure 1: RAFT Kaplan-Meier Analysis for the Tachycardia-free period from Day 1 of Randomization - Figure 1

The given text represents a graph showing the proportion of patients without an event over time for three different groups: Placebo, Propafenone ER 325 mg bid, Propafenone ER 225 mg bid, and Propafenone ER 425 mg bid. The x-axis has days mentioned on it, whereas the y-axis indicates the number of patients. The patients started on Day 273 & lasted up to 300 days. There is a note mentioned that on Day 231, one patient from the two that were left on Propafenone ER 325 mg bid had an event causing a 50% decline in the Kaplan-Meier curves.*

Structural Formula - Structure

Structural Formula - Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.